VSY Biotechnology BV and Carl Zeiss Meditec AG Settled Their Legal Disputes
AMSTERDAM, Feb. 15, 2019 /PRNewswire/ --
VSY Biotechnology BV and Carl Zeiss Meditec AG jointly announced that both companies resolved their legal and patent disputes with respect to Tri-ED 611. The companies agreed not to disclose the terms of the settlement.
Upcoming Life Sciences Events
- April 2024
- Singapore: Asia Bio Partnering Forum
- London: LSX World Congress
- May 2024
- Seoul: BIO KOREA 2024